Fulminant hepatic failure in the elderly: A clinicopathological study of autopsy cases aged over 65 years

Pathology International

Volumn 50, Issue 2, 2000, Pages 98-105

  Sawabe, Motoji ^a   Arai, Tomio ^a   Esaki, Yukiyoshi ^a   Fukazawa, Toshio ^a   Takubo, Kaiyo ^b   Hirokawa, Katsuiku ^c  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Fulminant hepatic failure; Fulminant hepatitis; Hepatic encephalopathy; Pathology

Indexed keywords

AGED; AGING; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER FAILURE; LIVER NECROSIS; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; NECROSIS; ORGAN SIZE;

EID: 0034102450     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2000.01005.x     Document Type: Article

References (33)

1. 1 Fenster LF. Viral hepatitis in the elderly. An analysis of 23 patients over 65 years of age. Gastroenterology 1965; 49: 262-271.
2. 2 Gibinski K, Fojt E, Suchan L. Hepatitis in the aged. Digestion 1973; 8: 254-260.
3. 3 Goodson JD, Taylor PA, Campion EW, Richter JM, Wands J. The clinical course of acute hepatitis in the elderly patient. Arch. Intern. Wed. 1982; 142: 1485-1488.
4. 4 Mörl M. Special pathogenetic forms of hepatitis in old age. Z. Gerontol. 1982; 15: 113-117 (German article with English abstract).
5. 5 Hirokawa K, Utsuyama M, Kasai M, Kurashima C. Aging and immunity. Acta Pathol. Jpn. 1992; 42: 537-548.
6. 6 Kondo Y, Tsukada K, Takeuchi T et al. High carrier rate after hepatitis B virus infection in the elderly. Hepatology 1993; 18: 768-774.
7. 7 Peters RL. Viral hepatitis: a pathologic spectrum. Am. J. Med. Sci. 1975; 270: 17-31.
8. 8 Peters RL. Acute and chronic varieties of viral hepatitis. In: Oda T, ed. Hepatitis Virus. University of Tokyo Press, Tokyo, 1978; 197-233.
9. 9 Peters RL, Omata M, Aschavai M, Liew CT. Protracted viral hepatitis with impaired regeneration. In: Vyas GN, Cohen S, Schmidt R, eds. Viral Hepatitis. Franklin Institute Press, Philadelphia, 1978; 79-84.
10. 10 Trey C. The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival. Can. Med. Assoc. J. 1972; 106: 525-526.
11. 11 Takahashi Y, Shimizu M. Study Group of Fulminant Hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicentre study. J. Gastroenterol. Hepatol. 1991; 6: 159-164.
12. 12 Thung SN, Gerber MA. The formation of elastic fibers in livers with massive hepatic necrosis. Arch. Pathol. Lab. Med. 1982; 106: 468-469.
13. 13 Lucké B. The pathology of fatal epidemic hepatitis. Am. J. Pathol. 1944; 20: 471-593.
14. 14 Lucké B, Mallory T. The fulminant form of epidemic hepatitis. Am. J. Pathol. 1946; 22: 867-945.
15. 15 Edmondson HA, Peters RL. Fulminant viral hepatitis. In: Kissane JM, ed. Anderson's Pathology, 9th edn. CV Mosby, St Louis, 1990;1219-1223.
16. 16 Boyer JL, Klatskin G. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N. Eng. J. Med. 1970; 283: 1063-1071.
17. 17 Aimi S, Yasoshima S, Sugai M, Sato B, Sakai T, Nakajima Y. Studies on the weight and size of internal organs of normal Japanese. Acta Pathol. Jpn. 1952; 2: 173-200.
18. 18 Inoue T, Otsu S. Statistical analysis of the organ weights in 1,000 autopsy cases of Japanese aged over 60 years. Acta Pathol. Jpn. 1987; 37: 343-359.
19. 19 Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
20. 20 Horney JT, Galambos JT. The liver during and after fulminant hepatitis. Gastroenterology 1977; 73: 639-645.
21. 21 Hanau C, Munoz SJ, Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology 1995; 21: 345-351.
22. 22 Omata M, Ehata T, Yokosuka O, Hosoda K, Onto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N. Engl. J. Med. 1991; 324: 1699-1704.
23. 23 Ehata T, Omata M, Chuang WL et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J. Clin. Invest. 1993; 91: 1206-1213.
24. 24 Thung SN. The development of proliferating ductular structures in liver disease. An immunohistochemical study. Arch. Pathol. Lab. Med. 1990; 114: 407-411.
25. 25 Pastore G, Dentico P, Angarano G et al. Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis. J. Med. Virol. 1981; 7: 97-103.
26. 26 Tisdale WA. Subacute hepatitis. N. Eng. J. Med. 1963; 268: 85-89.
27. 27 Tisdale WA. Clinical and pathologic features of subacute hepatitis. Medicine 1966; 45: 557-563.
28. 28 Lucké B. The structure of the liver after recovery from epidemic hepatitis. Am. J. Pathol. 1944; 20: 595-619.
29. 29 Karvountzis GG, Redeker AG, Peters RL. Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterology 1974; 67: 870-877.
30. 30 Schmid M, Pirovino M, Altorfer J et al. Acute viral hepatitis B with bridging necrosis: a follow-up study. Liver 1981; 1: 222-229.
31. 31 Ware AJ, Cuthbert JA, Shorey J, Gurian LE, Eigenbrodt EH, Combes B. A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis. Gastroenterology 1981; 80: 219-224.
32. 32 Yoshiba M, Dehara K, Inoue K, Okamoto H, Mayumi M. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology 1994; 19: 829-835.
33. 33 Farci P, Alter HJ, Shimoda A et al. Hepatitis C virus-associated fulminant hepatic failure. N. Engl. J. Med. 1996; 335: 631-634.